2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Endometrial Neoplasms
8
Uterine Cervical Neoplasms
6
Leiomyoma
6
Ovarian Neoplasms
4
Myofibroma
3
Uterine Neoplasms
2
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
2
Carcinoma, Ovarian Epithelial
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Prolapse
1
Uterine Cervical Dysplasia
1
Sarcoma
1
Precancerous Conditions
1
Metrorrhagia
1
Menstruation Disturbances
1
Menorrhagia
1
Hysterectomy
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Fallopian Tube Neoplasms
1
Endometriosis
1
Endometrial Hyperplasia
1
Disease
1
Carcinoma, Squamous Cell
1
Carcinoma, Endometrioid
1
Carcinoma, Adenosquamous
1
Adenomyosis
1
Adenocarcinoma
1
Interventions
relugolix
4
Sutures
2
vilaprisan
1
tibolone
1
cetrorelix
1
Uterine Myomectomy
1
Triptorelin Pamoate
1
Transcranial Direct Current Stimulation
1
Tablets
1
Surgical Procedures, Operative
1
Surgical Instruments
1
Rocuronium
1
Robotic Surgical Procedures
1
Radiotherapy
1
Radiation
1
Norethindrone Acetate
1
Menotropins
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Indocyanine Green
1
Incidence
1
Immunonutrition Diet
1
Hysteroscopy
1
Hysterectomy
1
Gonadotropins
1
Gonadotropin-Releasing Hormone
1
Fluconazole
1
Estradiol
1
Endoscopes
1
Electrocoagulation
1
Danazol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometriosis
×
Hysterectomy
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled